This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Massachusetts Institute of Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,268 
1 out of 8,594 
Years Active: 2024
Title: Michael Agius: Innovator in Proteolysis Targeting Chimeric Molecules
Introduction
Michael Agius is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative compounds that target dysregulated proteins for degradation.
Latest Patents
Agius holds a patent for "Proteolysis targeting chimeric molecules (PROTACs) with functional handles and uses thereof." This patent discloses multifunctional compounds, conjugates, macromolecules, and polymers designed to target dysregulated proteins for degradation. Additionally, it includes methods of preparation, compositions, kits, and methods of use related to these degraders.
Career Highlights
Throughout his career, Michael Agius has worked with esteemed institutions such as the Massachusetts Institute of Technology and Dana-Farber Cancer Institute Inc. His work has been pivotal in advancing research in the field of protein degradation.
Collaborations
Agius has collaborated with notable individuals in his field, including Jeremiah Allen Johnson and Hung Vanthanh Nguyen. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Michael Agius is a key figure in the development of proteolysis targeting chimeric molecules, with a focus on creating effective solutions for targeting dysregulated proteins. His contributions to biotechnology continue to influence the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile